CONCORD DRUGS
|
The Current P/B Ratio of CONCORD DRUGS is 2.20.
| Share Price | ₹80.9 | Sep 10,2026 |
| Market Cap | ₹106.8 Cr | |
| Book Value | ₹48.5 Cr | Mar2026 - Consolidated Results |
| Price/Book | 2.20x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of CONCORD DRUGS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹106.8 Cr] as on Sep 10,2026
(/) Book Value [ ₹48.5 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 2.20x ]
Thus, for CONCORD DRUGS , the investors are currently willing to pay '2.20 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CONCORD DRUGS !
The chart below summarizes the trend in P/B Ratio of CONCORD DRUGS over the last five years.
Historical PB (Price/Book ) ratio chart of CONCORD DRUGS
PB Ratio Performance Analysis for CONCORD DRUGS
- CONCORD DRUGS 's p/b ratio for fiscal years ending Mar2025 to Mar2022 averaged 0.92x.
- CONCORD DRUGS 's operated at median p/b ratio of 0.91x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, CONCORD DRUGS 's p/b ratio peaked in Mar2024 at 1.04x.
- CONCORD DRUGS 's p/b ratio hit its five-year low in Mar2023 of 0.82x.
How does CONCORD DRUGS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| CONCORD DRUGS | 48.51 | 2.20 | 106.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.35 | 447,236.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 14.90 | 249,673.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 22.35 | 187,460.0 |
| CIPLA LTD | 34,369.40 | 3.24 | 111,484.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.52 | 95,220.3 |
| MANKIND PHARMA LTD | 16,252.60 | 5.71 | 92,769.9 |
| LUPIN LTD | 22,384.10 | 4.24 | 94,882.7 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.11 | 111,521.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.53 | 96,030.6 |
| LAURUS LABS LTD | 5,275.08 | 19.83 | 104,604.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CONCORD DRUGS 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.20x |
| Max industry PB | 22.35x |
| Median industry PB | 4.24x |
| Average industry PB | 7.91x |
You may also like the below Video Courses